JINGHUA PHARMACEUTICAL GROUP CO.(SZ:002349) Tong Hua Shun Cai Bao·2025-04-14 12:21Financial Performance - The company's basic earnings per share decreased by 8% to 0.2899 yuan in 2024 from 0.3151 yuan in 2023 [1] - Total revenue fell by 8.98% to 5.37 billion yuan in 2024 compared to 5.9 billion yuan in 2023 [1] - Net profit also declined by 8.15% to 1.24 billion yuan in 2024 from 1.35 billion yuan in 2023 [1] - The return on equity decreased by 12.23% to 10.69% in 2024 from 12.18% in 2023 [1] - The company's net asset per share increased by 4.89% to 2.79 yuan in 2024 from 2.66 yuan in 2023 [1] - The undistributed profits per share rose by 10.48% to 1.16 yuan in 2024 from 1.05 yuan in 2023 [1] Shareholder Structure - The top ten unrestricted shareholders hold a total of 33,144.64 million shares, accounting for 77.66% of the circulating shares, with a decrease of 710.77 million shares compared to the previous period [1] - The largest shareholder, Jinghua Pharmaceutical Group Co., Ltd., holds 30,872.43 million shares, representing 72.34% of the total share capital, with no change [2] - Notable changes include a decrease of 573.21 million shares held by Tong Zhenming and an increase of 98.59 million shares held by Lin Liangdun [2] Dividend Distribution - The company announced a dividend distribution plan of 1.4 yuan per share (including tax) [4]